<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04136730</url>
  </required_header>
  <id_info>
    <org_study_id>HM-2019-021</org_study_id>
    <nct_id>NCT04136730</nct_id>
  </id_info>
  <brief_title>Effects of Home-based Resistance Exercise on Body Composition, Muscle Strength and Glycemic Control in People With Type 2 Diabetes.</brief_title>
  <official_title>Effects of Home-based Resistance Exercise on Body Composition, Muscle Strength and Glycemic Control in People With Type 2 Diabetes.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dasman Diabetes Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Glasgow</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Dasman Diabetes Institute</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study investigates the effects of home-based resistance exercise training, compared to a
      control group, on body composition, muscle strength and glycaemic control in people with type
      2 diabetes.

      Half participants will be in the home-based exercise group and half in the control group.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">August 1, 2019</start_date>
  <completion_date type="Anticipated">August 2020</completion_date>
  <primary_completion_date type="Anticipated">August 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glycated Haemoglobin concentration (mmol/mol)</measure>
    <time_frame>Change from baseline to 32 weeks</time_frame>
    <description>Glycated haemaglobin</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fat-free mass</measure>
    <time_frame>Change from baseline to 32 weeks</time_frame>
    <description>Whole body fat free mass</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short performance physical battery test</measure>
    <time_frame>Change from baseline to 32 weeks</time_frame>
    <description>Short performance physical battery test (0 (worst performance) to 12 (best performance))</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Grip strength</measure>
    <time_frame>Change from baseline to 32 weeks</time_frame>
    <description>Grip strength measured by handheld dynamometer</description>
  </other_outcome>
  <other_outcome>
    <measure>One rep max</measure>
    <time_frame>Change from baseline to 32 weeks</time_frame>
    <description>The maximum weight that can be lifted for a single repetition of leg extension and lateral pull down</description>
  </other_outcome>
  <other_outcome>
    <measure>Push up test</measure>
    <time_frame>Change from baseline to 32 weeks</time_frame>
    <description>Number of push ups that can be performed</description>
  </other_outcome>
  <other_outcome>
    <measure>BMI</measure>
    <time_frame>Change from baseline to 32 weeks</time_frame>
    <description>Body mass index</description>
  </other_outcome>
  <other_outcome>
    <measure>Body fat</measure>
    <time_frame>Change from baseline to 32 weeks</time_frame>
    <description>Total body fat measured via DEXA</description>
  </other_outcome>
  <other_outcome>
    <measure>Visceral fat</measure>
    <time_frame>Change from baseline to 32 weeks</time_frame>
    <description>Visceral adipose tissue measured by DEXA</description>
  </other_outcome>
  <other_outcome>
    <measure>Physical activity levels</measure>
    <time_frame>Change from baseline to 32 weeks</time_frame>
    <description>Physical activity levels measured with a wrist worn accelerometer</description>
  </other_outcome>
  <other_outcome>
    <measure>Quality of life score</measure>
    <time_frame>Change from baseline to 32 weeks</time_frame>
    <description>EQ-5D-DL questionnaire will be used (5 (worst) to 125 (best))</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Usual Care</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Home-based</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Home-based resistance exercise training</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Home-based</intervention_name>
    <description>Resistance exercise carried out unsupervised at home</description>
    <arm_group_label>Home-based</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Physician diagnosed type 2 diabetes

          -  No changes in anti-diabetic medication in the last 3 months

        Exclusion Criteria:

          -  Not currently or in the past year participating in any vigorous aerobic activity (&gt;1h
             per week) or any resistance exercise.

          -  BMI of 45 or higher

          -  Blood pressure of 160/100mmHg or higher

          -  Currently receiving insulin therapy
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ebaa AlOzairi</last_name>
    <role>Principal Investigator</role>
    <affiliation>Dasman Diabetes Institute</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Stuart Gray</last_name>
    <phone>01413302569</phone>
    <email>stuart.gray@glasgow.ac.uk</email>
  </overall_contact>
  <location>
    <facility>
      <name>Dasman Diabetes Institute</name>
      <address>
        <city>Kuwait City</city>
        <zip>15462</zip>
        <country>Kuwait</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Nicola Guess, PhD</last_name>
      <phone>+965 2224 2999</phone>
      <phone_ext>2033</phone_ext>
      <email>Nicola.Guess@dasmaninstitute.org</email>
    </contact>
  </location>
  <location_countries>
    <country>Kuwait</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>October 21, 2019</study_first_submitted>
  <study_first_submitted_qc>October 21, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">October 23, 2019</study_first_posted>
  <last_update_submitted>July 16, 2020</last_update_submitted>
  <last_update_submitted_qc>July 16, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 20, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dasman Diabetes Institute</investigator_affiliation>
    <investigator_full_name>Dr. Ebaa Al Ozairi</investigator_full_name>
    <investigator_title>Chief Medical Officer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Diabetes Mellitus</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

